Study of Metabolic Features Linked to Melanoma Spread
This study observes metabolic features of human melanoma tumors in adults with skin melanoma.
Key facts
- Who runs it
- University of Texas Southwestern Medical Center
- Where
- Dallas, United StatesSee the site
- Trial code
- Registry title
- Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 1 Aug 2018
- Expected to end
- 1 Aug 2028
- Type of study
- Observational, 2 groups
- Record updated
- 2 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a known or likely melanoma skin lesion who need surgery to take a sample or remove it. It looks at the metabolic features of melanoma tumors.
- Age
- Over 18 years
- Sex
- All sexes can join
- Disease stage
- Known or probable malignant melanoma lesions that need a surgical biopsy or excision
Main reasons for not taking part
- Not a candidate for surgery
- Poorly controlled diabetes
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Patients with known or probable malignant melanoma lesions requiring surgical biopsy or excision
- Subjects of all races and ethnic origins over age 18
Who cannot take part
- Not a surgical candidate
- Poorly controlled diabetes
Where in United States
- University of Texas Southwestern Medical CenterDallas, United StatesContact: Aleuna LeeTaking people
About the trial
What the trial wants to find out
The goal of this study is to observe metabolic features associated with human melanoma tumors.
The 2 groups in the trial
- 13C-glucose infusion
Tumor samples of patients who receive the optional 13C-glucose infusion will be studied using flux analysis and metabolomic profiling.
- No 13C-glucose infusion
Tumor samples of patients who do not receive the optional 13C-glucose infusion will be studied using metabolomic profiling alone.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
- Plain-language title
- Study of Metabolic Features Linked to Melanoma SpreadGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 2 June 2026